Eiji Tanaka

17.7k total citations · 2 hit papers
280 papers, 11.2k citations indexed

About

Eiji Tanaka is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Eiji Tanaka has authored 280 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Epidemiology, 190 papers in Hepatology and 56 papers in Surgery. Recurrent topics in Eiji Tanaka's work include Liver Disease Diagnosis and Treatment (154 papers), Hepatitis C virus research (130 papers) and Hepatitis B Virus Studies (100 papers). Eiji Tanaka is often cited by papers focused on Liver Disease Diagnosis and Treatment (154 papers), Hepatitis C virus research (130 papers) and Hepatitis B Virus Studies (100 papers). Eiji Tanaka collaborates with scholars based in Japan, United States and Egypt. Eiji Tanaka's co-authors include Kendo Kiyosawa, Akihiro Matsumoto, Kaname Yoshizawa, Takeji Umemura, Tetsuya Ichijo, Satoru Joshita, Naoki Tanaka, Harvey J. Alter, Michiharu Komatsu and Seiichi Furuta and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Eiji Tanaka

276 papers receiving 10.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

2003 1.2k citations Eiji Tanaka, Seiji Kawasaki et al. profile →
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

1990 1.0k citations Kendo Kiyosawa, Takeshi Sodeyama et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eiji Tanaka Japan	53	7.9k	7.7k	1.7k	1.1k	837	280	11.2k
Massimo Colombo Italy	47	9.6k 1.2×	8.5k 1.1×	1.0k 0.6×	1.0k 0.9×	787 0.9×	201	11.8k
Graeme Alexander United Kingdom	49	7.2k 0.9×	7.2k 0.9×	1.6k 0.9×	1.3k 1.2×	711 0.8×	191	11.9k
Fumitaka Suzuki Japan	54	9.6k 1.2×	9.1k 1.2×	866 0.5×	778 0.7×	612 0.7×	404	11.5k
Wan‐Long Chuang Taiwan	53	8.5k 1.1×	8.3k 1.1×	732 0.4×	939 0.8×	525 0.6×	513	11.1k
Calogero Cammà Italy	62	7.5k 0.9×	8.4k 1.1×	2.3k 1.3×	586 0.5×	1.3k 1.6×	271	12.0k
Pietro Andreoné Italy	49	7.7k 1.0×	7.1k 0.9×	1.3k 0.7×	571 0.5×	822 1.0×	346	9.9k
Yasuji Arase Japan	52	9.1k 1.1×	8.7k 1.1×	726 0.4×	878 0.8×	532 0.6×	394	11.6k
Sheng‐Nan Lu Taiwan	54	9.4k 1.2×	9.5k 1.2×	948 0.5×	879 0.8×	871 1.0×	379	12.3k
Francesco Callea Italy	33	4.7k 0.6×	4.5k 0.6×	1.5k 0.9×	930 0.8×	776 0.9×	158	8.0k
Masahiro Kobayashi Japan	57	11.3k 1.4×	9.8k 1.3×	1.4k 0.8×	1.7k 1.5×	1.7k 2.0×	473	15.3k

Countries citing papers authored by Eiji Tanaka

Since Specialization

Citations

This map shows the geographic impact of Eiji Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Tanaka more than expected).

Fields of papers citing papers by Eiji Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Tanaka. The network helps show where Eiji Tanaka may publish in the future.

Co-authorship network of co-authors of Eiji Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Tanaka. A scholar is included among the top collaborators of Eiji Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Tanaka. Eiji Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Naoki, Takefumi Kimura, Naoyuki Fujimori, et al.. (2019). Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology. 25(2). 163–177. 109 indexed citations

Joshita, Satoru, Takeji Umemura, Yūki Yamashita, et al.. (2019). Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis. Hepatology Research. 49(10). 1236–1243. 29 indexed citations

Joshita, Satoru, Yūki Yamashita, Ayumi Sugiura, et al.. (2019). Clinical utility of FibroScan as a non‐invasive diagnostic test for primary biliary cholangitis. Journal of Gastroenterology and Hepatology. 35(7). 1208–1214. 22 indexed citations

Saito, Hiromi, Takeji Umemura, Satoru Joshita, et al.. (2018). Association between KIR-HLA combination and ulcerative colitis and Crohn’s disease in a Japanese population. PLoS ONE. 13(4). e0195778–e0195778. 22 indexed citations

Komatsu, Michiharu, Naoki Tanaka, Takefumi Kimura, et al.. (2018). Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patients. Hepatology Research. 48(13). 1092–1098. 14 indexed citations

Yamazaki, Tomoo, Satoru Joshita, Takeji Umemura, et al.. (2018). Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C. PLoS ONE. 13(4). e0195632–e0195632. 13 indexed citations

Umemura, Takeji, Tomoo Yamazaki, Satoru Joshita, et al.. (2018). Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C. Cytokine. 111. 357–363. 4 indexed citations

Yamazaki, Tomoo, Takeji Umemura, Satoru Joshita, et al.. (2018). A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis. Scientific Reports. 8(1). 11924–11924. 8 indexed citations

Joshita, Satoru, Yuki Ichikawa, Takeji Umemura, et al.. (2017). Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatology Research. 48(4). 275–285. 31 indexed citations

10.

Umemura, Takeji, Satoru Joshita, Tomoo Yamazaki, et al.. (2016). Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis. Liver International. 37(6). 897–905. 18 indexed citations

11.

Shibata, Soichiro, Satoru Joshita, Takeji Umemura, et al.. (2016). Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. SpringerPlus. 5(1). 998–998. 12 indexed citations

12.

Umemura, Takeji, Masao Ôta, Yoshihiko Katsuyama, et al.. (2014). KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Human Immunology. 75(8). 822–826. 11 indexed citations

13.

Kumada, Hiromitsu, Takeshi Okanoue, Morikazu Onji, et al.. (2010). Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatology Research. 40(1). 8–13. 81 indexed citations

14.

Fujiwara, Keiichi, Hiroshige Kojima, Yutaka Yonemitsu, et al.. (2009). Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities. Liver International. 29(6). 838–845. 14 indexed citations

15.

Akamatsu, Taiji, et al.. (2009). USEFULNESS OF DOUBLE BALLOON ENTEROSCOPY AND VIDEO CAPSULE ENDOSCOPY FOR THE DIAGNOSIS AND MANAGEMENT OF PRIMARY FOLLICULAR LYMPHOMA OF THE GASTROINTESTINAL TRACT IN ITS EARLY STAGES. Digestive Endoscopy. 22(1). 33–38. 22 indexed citations

16.

Higuchi, Makoto, Eiji Tanaka, & Kendo Kiyosawa. (2002). Epidemiology and Clinical Aspects on Hepatitis C. Japanese Journal of Infectious Diseases. 55(3). 69–77. 73 indexed citations

17.

Yamaura, Takahiro, Kaname Yoshizawa, Atsushi Maruyama, et al.. (2001). A CASE OF HEPATIC ANGIOSARCOMA IN WHICH LAPAROSCOPY WAS USEFUL FOR THE DIAGNOSIS. Acta gastro-enterologica belgica. 43(12). 2250–2257. 2 indexed citations

18.

Hara, Masao, et al.. (1999). Gastric enterochromaffin-like-cell tumor with liver and splenic metastases. Journal of Gastroenterology. 34(3). 383–386. 5 indexed citations

19.

Kobayashi, Masakazu, Eiji Tanaka, Jun Nakayama, et al.. (1999). Detection of GB virus-C/hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue. Journal of Medical Virology. 57(2). 114–121. 21 indexed citations

20.

Tanaka, Eiji, Kendo Kiyosawa, Akihiro Matsumoto, et al.. (1994). PREVALENCE OF HEPATITIS C VIRUS WITH DIFFERENT GENO-TYPES DETERMINED BY A GROUP-SPECIFIC ANTIBODY ASSAY IN JAPANESE PATIENTS WITH CHRONIC LIVER DISEASES DUE TO HEPATITIS C VIRUS INFECTION. Japanese Journal of Medical Science and Biology. 47(1). 47–57. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact